Breast Neoplasm
168
21
36
86
Key Insights
Highlights
Success Rate
83% trial completion
Published Results
25 trials with published results (15%)
Research Maturity
86 completed trials (51% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
10.1%
17 terminated out of 168 trials
83.5%
-3.0% vs benchmark
5%
9 trials in Phase 3/4
29%
25 of 86 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 86 completed trials
Clinical Trials (168)
Decision Aid Website in Helping to Make Decisions About Fertility in Participants With Cancer
Evaluating an AI-Based Mobile Application for Chemotherapy Support in Breast Cancer Patients
Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Combination Study of SV-BR-1-GM With Retifanlimab
Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy
Cryoablation vs Lumpectomy in T1 Breast Cancers
HOBBIT 3: Mental Exercises and Temporal Alteration
Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring
Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer
Decongestive Exercise and Compression for Breast Cancer Related Lymphedema Management
[18F]ISO-1 Positron Emission Tomography (PET/CT) in Primary Breast Cancer
A Prospective Study to Develop and Clinically Validate an in Vitro Diagnostic Medical Device That Uses Blood to Classify Patients at High Risk for Breast Cancer
Study of Anxiety After a Session of Energy Resonance by Cutaneous Stimulation
Health Economic Evaluation of an Adapted Physical Activity Program for Women With Breast Cancer
Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC)
Post Marketing Surveillance Study to Observe Safety and Efficacy of IBRANCE®
A Study of Ado-trastuzumab Emtansine (T-DM1)-Induced Peripheral Neuropathy in HER2-positive Breast Cancer Patients
Adjusting the Dose of Therapeutic Exercise to Prevent Neurotoxicity Due to Anticancer Treatment (ATENTO)
Preventing Chemotherapy-induced Peripheral Neuropathy Using PRESIONA Exercise Program